Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 24;11(2):113-121.
doi: 10.4103/tjo.tjo_12_21. eCollection 2021 Apr-Jun.

Advances in refractive corneal lenticule extraction

Affiliations
Review

Advances in refractive corneal lenticule extraction

Matthias Fuest et al. Taiwan J Ophthalmol. .

Abstract

Refractive errors are the leading cause of reversible visual impairment worldwide. In addition to the desired spectacle independence, refractive procedures can improve quality of life, working ability, and daily working performance. Refractive corneal lenticule extraction (RCLE) is a relatively new technique, dependent only on a femtosecond laser (FS). This leads to potential benefits over laser-assisted in situ keratomileusis (LASIK) including a quicker recovery of dry eye disease, a larger functional optical zone, and no flap-related complications. SMILE, available with the VisuMax FS (Carl Zeiss Meditec AG, Jena, Germany), is the most established RCLE application, offering visual and refractive outcomes comparable to LASIK. SmartSight (SCHWIND eye-tech-solutions GmbH, Kleinostheim, Germany) and CLEAR (Ziemer Ophthalmic Systems AG, Port, Switzerland) are two new RCLE applications that received Conformité Européenne (CE) approval in 2020. In this article, we review refractive and visual outcomes, advantages, and disadvantages of RCLE and also report on the latest advances in RCLE systems.

Keywords: Cornea corneal surgery; laser refraction; ocular refractive surgical procedures.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interests in this paper.

Figures

Figure 1
Figure 1
Three femtosecond laser (FS) platforms currently allow refractive corneal lenticule extraction (RCLE). The SCHWIND ATOS FS (a; SCHWIND eye-tech-solutions GmbH, Kleinostheim, Germany) received CE approval for its SmartSight application in July 2020 and the FEMTO LDV Z8 FS (c; Ziemer Ophthalmic Systems AG, Port, Switzerland) for its CLEAR program in April 2020. SMILE, available with the VisuMax FS (b; Carl Zeiss Meditec, Jena, Germany), is the only current RCLE application with CE and FDA approval. The images were provided by the manufacturers.[252627]
Figure 2
Figure 2
Guiding incisions (green) and tunnels (red) used in modern refractive corneal lenticule extraction (RCLE). In this case one incision guides the surgeon to the posterior and one to the anterior surfaces of the lenticule to be delineated directly and independently. This option is available with the CLEAR program on the FEMTO LDV Z8 platform (Ziemer Ophthalmic Systems AG, Port, Switzerland) and helps to prevent lenticule mis-dissection, one of the most common intraoperative complications in RCLE[27]
Figure 3
Figure 3
Intraoperative optical coherence tomography (iOCT) can be used in CLEAR on the FEMTO LDV Z8 platform (Ziemer Ophthalmic Systems AG, Port, Switzerland)[27]

References

    1. Lou L, Yao C, Jin Y, Perez V, Ye J. Global patterns in health burden of uncorrected refractive error. Invest Ophthalmol Vis Sci. 2016;57:6271–7. - PubMed
    1. Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012;379:1739–48. - PubMed
    1. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036–42. - PubMed
    1. Kim TI, Alió Del Barrio JL, Wilkins M, Cochener B, Ang M. Refractive surgery. Lancet. 2019;393:2085–98. - PubMed
    1. Ang M, Gatinel D, Reinstein DZ, Mertens E, Alió Del Barrio JL, Alió JL. Refractive surgery beyond 2020. Eye (Lond) 2021;35:362–82. - PMC - PubMed